Ignite Creation Date:
2024-10-26 @ 3:41 PM
Last Modification Date:
2024-10-26 @ 3:41 PM
Study NCT ID:
NCT06612788
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
None
First Post:
2024-09-20
Brief Title:
Exablate for LIFU Neuromodulation in Patients with Opioid Use Disorder OUD
Sponsor:
None
Organization:
None
Study Overview
Official Title:
A Feasibility Clinical Trial of Exablate for Low Intensity Focused Ultrasound Neuromodulation in Patients with Opioid Use Disorder OUD Andor Other Substance Abuse Disorders SUDs
Status:
ACTIVE_NOT_RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this clinical trial is to investigate Low Intensity Focused Ultrasound LIFU using the Exablate Model 4000 Type 2021 as an adjunctive neuromodulatory treatment for OUD Opioid Use Disorder by assessing its safety and tolerability in subjects with OUD
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None